
|Videos|October 20, 2015
DEA Audits of Pharmacies on the Rise
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.
This video was recorded at the National Community Pharmacists Association's (NCPA) 2015 Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
5














































































































































































































